Speaker Profile
Biography
Felix Baldauf-Lenschen is the Founder and CEO of Altis Labs, the AI endpoint company accelerating clinical trials. Felix founded Altis on the premise that AI's greatest potential lies in generating better evidence, faster. In close partnership with leading cancer centers, his team developed IPRO, an AI model, on the industry’s largest multimodal database spanning over 500,000 cancer patient years. Leading global drug developers use IPRO to measure therapeutic efficacy in their Phase I-III oncology trials 12+ months earlier than standard measures, helping bring the most effective new treatments to patients sooner.
Talk
Accelerating Evidence Generation with AI Endpoints
AI endpoints can accelerate evidence generation to predict true efficacy. Had IPRO, an AI endpoint, been prospectively implemented in the MARIPOSA Phase III trial, a significant treatment effect would have been detected 11 months prior to the primary analysis. AI endpoints have the potential to accelerate the delivery of life-extending therapies to patients.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
Day 1 / Wed · Jan 27
Day 2 / Thu · Jan 28
Day 3 / Fri · Jan 29
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
